Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value:
$116.64M
Total Bought:
$38.09M
Total Sold:
$105.85M
Net Transaction:
-$67.76M
Notable People:
Slanix Paul T Alex
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Intra-Cellular Therapies Inc0147,750+147,750$0$12.34M10.58%+$12.34M
Tarsus Pharmaceuticals, Inc.(TARS)321,898173,144-148,754$10.59M$9.59M8.22%-$1.00M
Insmed Incorporated(INSM)150,833114,360-36,473$11.01M$7.90M6.77%-$3.12M
Axsome Therapeutics, Inc.(AXSM)066,661+66,661$0$5.64M4.84%+$5.64M
Xenon Pharmaceuticals Inc.(XENE)211,791129,291-82,500$8.34M$5.07M4.35%-$3.27M
CG Oncology, Inc.(CGON)263,266174,048-89,218$9.93M$4.99M4.28%-$4.94M
Merus N V208,244116,796-91,448$10.40M$4.91M4.21%-$5.49M
Blueprint Medicines Corp106,08055,892-50,188$9.81M$4.87M4.18%-$4.94M
Janux Therapeutics, Inc.(JANX)108,81190,292-18,519$4.94M$4.83M4.14%-$109.0K
Centessa Pharmaceuticals PlcADS309,614244,538-65,076$4.95M$4.10M3.51%-$854.7K
Soleno Therapeutics Inc087,629+87,629$0$3.94M3.38%+$3.94M
Geron Corporation(GERN)1,331,0531,074,824-256,229$6.04M$3.80M3.26%-$2.24M
Alumis Inc418,416445,259+26,843$4.47M$3.50M3.00%-$968.9K
Praxis Precision Medicines, Inc.(PRAX)73,18544,982-28,203$4.21M$3.46M2.97%-$749.3K
Trevi Therapeutics, Inc.(TRVI)1,322,800781,489-541,311$4.42M$3.22M2.76%-$1.20M
Enliven Therapeutics Inc234,856141,710-93,146$6.00M$3.19M2.73%-$2.81M
Korro Bio, Inc.(KRRO)070,678+70,678$0$2.69M2.31%+$2.69M
Jasper Therapeutics, Inc.(JSPR)399,466122,424-277,042$7.51M$2.62M2.24%-$4.90M
EyePoint, Inc.(EYPT)0348,000+348,000$0$2.59M2.22%+$2.59M
Whitehawk Therapeutics, Inc.(WHWK)0817,939+817,939$0$2.58M2.21%+$2.58M
Atyr Pharma Inc0699,730+699,730$0$2.53M2.17%+$2.53M
89bio Inc0317,833+317,833$0$2.49M2.13%+$2.49M
Tyra Biosciences, Inc.(TYRA)270,075175,063-95,012$6.35M$2.43M2.09%-$3.92M
Dianthus Therapeutics, Inc.(DNTH)0106,434+106,434$0$2.32M1.99%+$2.32M
Mind Medicine Mindmed Inc788,508330,275-458,233$4.49M$2.30M1.97%-$2.19M
Edgewise Therapeutics, Inc.(EWTX)187,69583,176-104,519$5.01M$2.22M1.90%-$2.79M
Springworks Therapeutics Inc227,70054,692-173,008$7.30M$1.98M1.69%-$5.32M
Context Therapeutics Inc.(CNTX)1,757,5241,576,762-180,762$3.44M$1.66M1.42%-$1.79M
Promis Neurosciences Inc1,592,6051,592,6050$1.99M$1.51M1.29%-$481.3K
Climb Bio, Inc.(CLYM)1,229,292760,225-469,067$6.26M$1.37M1.17%-$4.89M
Applied Therapeutics Inc618,3320-618,332$5.26M$0—-$5.26M
Disc Medicine, Inc.(IRON)100,0000-100,000$4.91M$0—-$4.91M
Kura Oncology, Inc.(KURA)294,0810-294,081$5.75M$0—-$5.75M
Longboard Pharmaceuticals In240,8920-240,892$8.03M$0—-$8.03M
Perspective Therapeutics, Inc.(CATX)341,7390-341,739$4.56M$0—-$4.56M
Relay Therapeutics, Inc.(RLAY)626,0580-626,058$4.43M$0—-$4.43M
Revolution Medicines, Inc.(RVMD)163,5000-163,500$7.41M$0—-$7.41M
Sarepta Therapeutics, Inc.(SRPT)72,0000-72,000$8.99M$0—-$8.99M
Page 1 of 1
Ally Bridge Group (NY) LLC — 13F Holdings — Q4 2024 | TickerTrail